Skye Bioscience, Inc. Research and Development Expense
Skye Bioscience, Inc. (SKYE) reported Research and Development Expense of $1.79 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-07
- Skye Bioscience, Inc. research and development expense for the quarter ending 2023-06-30 was $1.79M, a 25.31% increase year-over-year.
- Skye Bioscience, Inc. research and development expense for the quarter ending 2023-03-31 was $1.18M, a 6.38% decline year-over-year.
- Skye Bioscience, Inc. research and development expense for the quarter ending 2022-12-31 was $1.54M, a 38.07% increase year-over-year.
- Skye Bioscience, Inc. research and development expense for the quarter ending 2022-09-30 was $1.78M, a 443.65% increase year-over-year.
- Skye Bioscience, Inc. research and development expense for fiscal 2022 was $6.01M, a 105.08% increase from fiscal 2021.
- Skye Bioscience, Inc. research and development expense for fiscal 2021 was $2.93M, a 50.76% increase from fiscal 2020.
- Skye Bioscience, Inc. research and development expense for fiscal 2020 was $1.94M, a 13.12% decline from fiscal 2019.
- Skye Bioscience, Inc. research and development expense for fiscal 2019 was $2.24M, a 578.24% increase from fiscal 2018.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.79M 10-Q · filed 2023-08-07 | $2.97M 10-Q · filed 2023-08-07 | $4.51M derived: sum of 3 quarters · filed 2023-08-07 | $6.29M derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | $1.18M 10-Q · filed 2023-05-12 | $2.72M derived: sum of 2 quarters · filed 2023-05-12 | $4.50M derived: sum of 3 quarters · filed 2023-05-12 | $5.93M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.32M derived: sum of 2 quarters · filed 2023-03-31 | $4.75M derived: sum of 3 quarters · filed 2023-08-07 | $6.01M 10-K · filed 2023-03-31 |
| 2022-09-30 | $1.78M 10-Q · filed 2022-11-14 | $3.21M derived: sum of 2 quarters · filed 2023-08-07 | $4.47M 10-Q · filed 2022-11-14 | $5.59M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-06-30 | $1.43M 10-Q · filed 2023-08-07 | $2.69M 10-Q · filed 2023-08-07 | $3.81M derived: sum of 3 quarters · filed 2023-08-07 | $4.13M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $1.27M 10-Q · filed 2023-05-12 | $2.38M derived: sum of 2 quarters · filed 2023-05-12 | $2.71M derived: sum of 3 quarters · filed 2023-05-12 | $3.59M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.44M derived: sum of 2 quarters · filed 2023-03-31 | $2.32M derived: sum of 3 quarters · filed 2023-03-31 | $2.93M 10-K · filed 2023-03-31 |
| 2021-09-30 | $327.73K 10-Q · filed 2022-11-14 | $1.21M derived: sum of 2 quarters · filed 2022-11-14 | $1.82M 10-Q · filed 2022-11-14 | $2.19M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $880.67K 10-Q · filed 2022-08-15 | $1.49M 10-Q · filed 2022-08-15 | $1.86M derived: sum of 3 quarters · filed 2022-08-15 | $2.21M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $609.66K 10-Q · filed 2022-05-06 | $979.71K derived: sum of 2 quarters · filed 2022-05-06 | $1.33M derived: sum of 3 quarters · filed 2022-05-06 | $1.75M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $370.05K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $716.27K derived: sum of 2 quarters · filed 2022-03-28 | $1.14M derived: sum of 3 quarters · filed 2022-03-28 | $1.94M 10-K · filed 2022-03-28 |
| 2020-09-30 | $346.22K 10-Q · filed 2021-11-10 | $774.75K derived: sum of 2 quarters · filed 2021-11-10 | $1.57M 10-Q · filed 2021-11-10 | $2.29M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $428.53K 10-Q · filed 2021-08-06 | $1.23M 10-Q · filed 2021-08-06 | $1.94M derived: sum of 3 quarters · filed 2021-08-06 | $2.46M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $799.61K 10-Q · filed 2021-05-07 | $1.52M derived: sum of 2 quarters · filed 2021-05-07 | $2.03M derived: sum of 3 quarters · filed 2021-05-07 | $2.72M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $715.92K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.23M derived: sum of 2 quarters · filed 2021-03-02 | $1.92M derived: sum of 3 quarters · filed 2021-03-02 | $2.24M 10-K · filed 2021-03-02 |
| 2019-09-30 | $513.00K 10-Q · filed 2020-11-06 | $1.20M derived: sum of 2 quarters · filed 2020-11-06 | $1.52M 10-Q · filed 2020-11-06 | $1.76M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $688.04K 10-Q · filed 2020-08-13 | $1.01M 10-Q · filed 2020-08-13 | $1.25M derived: sum of 3 quarters · filed 2020-08-13 | $1.31M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $320.99K 10-Q · filed 2020-05-08 | $558.66K derived: sum of 2 quarters · filed 2020-05-08 | $625.95K derived: sum of 3 quarters · filed 2020-05-08 | $625.95K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $237.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $304.97K derived: sum of 2 quarters · filed 2020-03-23 | $304.97K derived: sum of 3 quarters · filed 2020-03-23 | $329.97K 10-K · filed 2020-03-23 |
| 2018-09-30 | $67.29K 10-Q · filed 2019-11-14 | $67.29K derived: sum of 2 quarters · filed 2019-11-14 | $92.29K 10-Q · filed 2019-11-14 | $162.29K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $25.00K 10-Q · filed 2019-08-09 | $95.00K derived: sum of 3 quarters · filed 2019-08-09 | $183.55K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $25.00K 10-Q · filed 2019-05-10 | $95.00K derived: sum of 2 quarters · filed 2019-05-10 | $183.55K derived: sum of 3 quarters · filed 2019-05-10 | $244.20K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $158.55K derived: sum of 2 quarters · filed 2019-03-14 | $219.20K derived: sum of 3 quarters · filed 2019-03-14 | $311.30K 10-K · filed 2019-03-14 |
| 2017-09-30 | $88.55K 10-Q · filed 2018-11-14 | $149.20K derived: sum of 2 quarters · filed 2018-11-14 | $241.30K 10-Q · filed 2018-11-14 | $504.50K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $60.65K 10-Q · filed 2018-08-10 | $152.75K 10-Q · filed 2018-08-10 | $415.95K derived: sum of 3 quarters · filed 2018-08-10 | $496.48K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $92.10K 10-Q · filed 2018-05-15 | $355.30K derived: sum of 2 quarters · filed 2018-05-15 | $435.82K derived: sum of 3 quarters · filed 2018-05-15 | $895.78K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $263.20K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $343.73K derived: sum of 2 quarters · filed 2018-03-19 | $803.68K derived: sum of 3 quarters · filed 2018-03-19 | $939.04K 10-K · filed 2018-03-19 |
| 2016-09-30 | $80.53K 10-Q · filed 2017-11-14 | $540.48K derived: sum of 2 quarters · filed 2017-11-14 | $675.84K 10-Q · filed 2017-11-14 | $1.02M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $459.96K 10-Q · filed 2017-08-11 | $595.32K 10-Q · filed 2017-08-11 | $938.55K derived: sum of 3 quarters · filed 2017-08-11 | $1.09M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $135.36K 10-Q · filed 2017-05-12 | $478.59K derived: sum of 2 quarters · filed 2017-05-12 | $630.88K derived: sum of 3 quarters · filed 2017-05-12 | $674.25K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $343.23K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $495.52K derived: sum of 2 quarters · filed 2017-03-10 | $538.89K derived: sum of 3 quarters · filed 2017-03-10 | $576.09K 10-K · filed 2017-03-10 |
| 2015-09-30 | $152.29K 10-Q · filed 2016-11-09 | $195.66K derived: sum of 2 quarters · filed 2016-11-09 | $232.86K 10-Q · filed 2016-11-09 | $265.36K derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | $43.37K 10-Q · filed 2016-08-12 | $80.57K 10-Q · filed 2016-08-12 | $113.07K derived: sum of 3 quarters · filed 2016-08-12 | $308.07K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $37.20K 10-Q · filed 2016-05-13 | $69.70K derived: sum of 2 quarters · filed 2016-05-13 | $264.70K derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | $32.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $227.50K derived: sum of 2 quarters · filed 2016-03-21 | $227.50K 10-K · filed 2016-03-21 | |
| 2014-09-30 | $195.00K 10-Q · filed 2015-11-12 | $195.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |